Product Information
PERPHENAZINE 4 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.1413 per EA under NDC 00591410201. Its NADAC has been published 463 times since Aug 16, 2017.
Strength
4 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591410201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PERPHENAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA207582On Market Since
5/30/2017
Pharmacological Classes
Price Statistics
The NADAC for PERPHENAZINE 4 MG TABLET has been published 463 times since Aug 16, 2017, and over the history we have for it it has declined 86.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1413 per EA |
|---|---|
| All-time high | $1.0908 (Nov 15, 2017) |
| All-time low | $0.1413 (Jun 17, 2026) |
| 52-week high | $0.2228 |
| 52-week low | $0.1413 |
| Median price | $0.3650 |
| Average price | $0.3802 |
| Largest weekly change | +63.8% (Dec 21, 2022) |
| Weeks tracked | 463 |
| Tracking since | Aug 16, 2017 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PERPHENAZINE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PERPHENAZINE 4 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.1413 per EA (NDC 00591410201), effective Jun 24, 2026.
How has the price of PERPHENAZINE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PERPHENAZINE 4 MG TABLET has declined 86.8%. It has been tracked across 463 weekly CMS publications since Aug 16, 2017.
What are the highest and lowest recorded NADAC prices for PERPHENAZINE 4 MG TABLET?
Since Aug 16, 2017, the NADAC for PERPHENAZINE 4 MG TABLET has ranged from a low of $0.1413 (Jun 17, 2026) to a high of $1.0908 (Nov 15, 2017), with a median of $0.3650 per EA.
Are there cheaper alternatives to PERPHENAZINE 4 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as PERPHENAZINE 4 MG TABLET, but none are currently priced below it.
Who manufactures PERPHENAZINE 4 MG TABLET?
PERPHENAZINE 4 MG TABLET (NDC 00591410201) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification